{ "id": "vaccines-benefits-safety", "slug": "vaccines", "topic": "Vaccines", "tag": "Vaccines", "kind": "overview", "presentation": "overview", "title": "Vaccines are safe and effective", "revision": "vaccine-2026-10-15", "locale": "en", "researchDate": "2026-10-14", "copyReviewedAt": "2026-10-15", "readerCopyEdition": "vaccine-clarity-2026-10-15", "assessment": "Source-grounded explanation · research draft", "summary": "Vaccines prevent diseases that can cause disability and death. Their benefits are supported by trials and large studies. Serious side effects are rare, and the balance depends on the vaccine, age and health of the person receiving it.", "scope": "", "geographicScope": { "kind": "global", "countryCodes": [], "jurisdictionCodes": [], "note": "Evidence and jurisdiction limits are stated beside the relevant claims." }, "question": "What does safe and effective mean for vaccines?", "evidence": [ { "id": "protection", "heading": "Vaccines prevent serious disease", "text": "A major review found about 95% protection against measles after one MMR dose. Long-term HPV studies found substantially less cervical cancer when vaccination began before exposure. Hepatitis B vaccination in infancy also reduced later liver cancer in a long-term trial. These are different vaccines and outcomes, not one universal success rate.", "sources": [ 1, 2, 3 ], "detailTopics": [ "mmr", "hpv-vaccines", "newborn-hepatitis-b" ], "sourceIds": [ "vaccine-update-m1", "vaccine-update-h1", "vaccine-update-b3" ] }, { "id": "safety", "heading": "Safety and side effects", "text": "A favorable benefit–risk balance does not mean zero side effects. Fever-related seizures can follow MMR, and mRNA COVID vaccines can rarely cause myocarditis. The vaccine, age, health and dose matter. The linked pages explain those risks directly.", "sources": [ 4, 5 ], "detailTopics": [ "covid-myocarditis", "mmr" ], "quickLink": "Safety and side effects", "sourceIds": [ "vaccine-update-m2", "vaccine-update-c3" ] }, { "id": "autism", "heading": "Specific concerns have specific evidence", "text": "Large studies do not support a causal link with autism. Ingredients and childhood schedules have also been studied. No single study tests every combination and every possible delayed effect; the answer comes from several kinds of evidence.", "sources": [ 6, 7 ], "detailTopics": [ "vaccines-autism", "vaccine-ingredients", "vaccine-schedule" ], "sourceIds": [ "vaccine-update-a1", "vaccine-update-s2" ] }, { "id": "different-vaccines", "heading": "The vaccine type matters", "text": "Injectable inactivated polio vaccine cannot cause poliovirus infection. Live oral polio vaccines have rare paralysis risks, and vaccine-descended virus can sometimes circulate and cause outbreaks. These real risks should not be transferred to a different vaccine or denied.", "sources": [ 8 ], "detailTopics": [], "sourceIds": [ "vaccine-update-x1" ] } ], "takeaway": "Vaccines prevent diseases that can cause disability and death.", "limits": [ "The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance." ], "questionsHeading": "Find the answer you need", "contextTitle": "", "contextIntro": "", "detail": "", "sources": [ { "id": "vaccine-update-m1", "title": "Vaccines for measles, mumps, rubella, and varicella in children", "publisher": "Cochrane, 2021", "url": "https://www.cochrane.org/evidence/CD004407_does-measles-mumps-rubella-and-varicella-mmrv-vaccine-protect-children-and-does-it-cause-harmful", "readerBlurb": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals.", "limit": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." }, "publicationTitle": "Vaccines for measles, mumps, rubella, and varicella in children", "archiveDate": "2026-10-14", "supports": [ "Vaccines prevent serious disease" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." ], "limitationsPublic": [ "Reviews effectiveness and harms in children. Different outcomes use different studies and participant totals." ] }, { "id": "vaccine-update-h1", "title": "What are the benefits and risks of different human papillomavirus (HPV) vaccines for preventing cervical cancer and other HPV-related disease?", "publisher": "Cochrane, 2025", "url": "https://www.cochrane.org/evidence/CD015363_what-are-benefits-and-risks-different-human-papillomavirus-hpv-vaccines-preventing-cervical-cancer", "readerBlurb": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction.", "limit": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction." }, "publicationTitle": "What are the benefits and risks of different human papillomavirus (HPV) vaccines for preventing cervical cancer and other HPV-related disease?", "archiveDate": "2026-10-14", "supports": [ "Vaccines prevent serious disease" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction." ], "limitationsPublic": [ "Outcome-specific evidence: the whole review population is not the infertility sample. Cervical-cancer benefit is a relative reduction." ] }, { "id": "vaccine-update-b3", "title": "Long-term efficacy of neonatal hepatitis B vaccination against hepatocellular carcinoma and other liver diseases: a 30-year follow-up study of the Qidong hepatitis B intervention study", "publisher": "PLOS Medicine, 2014", "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001774", "readerBlurb": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants.", "limit": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants." }, "publicationTitle": "Long-term efficacy of neonatal hepatitis B vaccination against hepatocellular carcinoma and other liver diseases: a 30-year follow-up study of the Qidong hepatitis B intervention study", "archiveDate": "2026-10-14", "supports": [ "Vaccines prevent serious disease" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants." ], "limitationsPublic": [ "Cluster-randomized trial in high-endemicity China; not a birth-versus-two-months trial in low-risk US infants." ] }, { "id": "vaccine-update-m2", "title": "Measles, Mumps, Rubella (MMR) Vaccine Safety", "publisher": "CDC", "url": "https://www.cdc.gov/vaccine-safety/vaccines/mmr.html", "readerBlurb": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison.", "limit": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." }, "publicationTitle": "Measles, Mumps, Rubella (MMR) Vaccine Safety", "archiveDate": "2026-10-14", "supports": [ "Safety and side effects" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." ], "limitationsPublic": [ "Explains known MMR side effects; combined MMRV has a different seizure-risk comparison." ] }, { "id": "vaccine-update-c3", "title": "FDA Approves Required Updated Warning in Labeling of mRNA COVID-19 Vaccines Regarding Myocarditis and Pericarditis", "publisher": "FDA, June 2025", "url": "https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-required-updated-warning-labeling-mrna-covid-19-vaccines-regarding-myocarditis-and", "readerBlurb": "Observed 2023–24-formulation incidence in days 1–7 is not an excess-risk estimate. Persistent MRI findings have uncertain long-term meaning.", "limit": "Observed 2023–24-formulation incidence in days 1–7 is not an excess-risk estimate. Persistent MRI findings have uncertain long-term meaning.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Observed 2023–24-formulation incidence in days 1–7 is not an excess-risk estimate. Persistent MRI findings have uncertain long-term meaning." }, "publicationTitle": "FDA Approves Required Updated Warning in Labeling of mRNA COVID-19 Vaccines Regarding Myocarditis and Pericarditis", "archiveDate": "2026-10-14", "supports": [ "Safety and side effects" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Observed 2023–24-formulation incidence in days 1–7 is not an excess-risk estimate. Persistent MRI findings have uncertain long-term meaning." ], "limitationsPublic": [ "Observed 2023–24-formulation incidence in days 1–7 is not an excess-risk estimate. Persistent MRI findings have uncertain long-term meaning." ] }, { "id": "vaccine-update-a1", "title": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism", "publisher": "WHO, 2025", "url": "https://www.who.int/news/item/11-12-2025-statement-gacvs-vaccines-autism", "readerBlurb": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.", "limit": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." }, "publicationTitle": "Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism", "archiveDate": "2026-10-14", "supports": [ "Specific concerns have specific evidence" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." ], "limitationsPublic": [ "Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects." ] }, { "id": "vaccine-update-s2", "title": "The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies", "publisher": "Institute of Medicine, 2013", "url": "https://www.nationalacademies.org/publications/13563", "readerBlurb": "Reviews schedule safety methods and evidence gaps; does not validate every future schedule.", "limit": "Reviews schedule safety methods and evidence gaps; does not validate every future schedule.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Reviews schedule safety methods and evidence gaps; does not validate every future schedule." }, "publicationTitle": "The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies", "archiveDate": "2026-10-14", "supports": [ "Specific concerns have specific evidence" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Reviews schedule safety methods and evidence gaps; does not validate every future schedule." ], "limitationsPublic": [ "Reviews schedule safety methods and evidence gaps; does not validate every future schedule." ] }, { "id": "vaccine-update-x1", "title": "Poliomyelitis", "publisher": "WHO", "url": "https://www.who.int/news-room/questions-and-answers/item/poliomyelitis", "readerBlurb": "Distinguishes inactivated injectable vaccine from live oral vaccine and its genuine rare risks.", "limit": "Distinguishes inactivated injectable vaccine from live oral vaccine and its genuine rare risks.", "access": "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "revision": "research-2026-10-15", "retrievedAt": "2026-10-14", "locale": "en", "type": "Evidence source", "geographicCoverage": { "kind": "undetermined", "countryCodes": [], "jurisdictionCodes": [], "note": "Distinguishes inactivated injectable vaccine from live oral vaccine and its genuine rare risks." }, "publicationTitle": "Poliomyelitis", "archiveDate": "2026-10-14", "supports": [ "The vaccine type matters" ], "limitationsInternal": [ "Mapped to the 14 October 2026 research archive; selected fresh checks and access limits recorded in output/live-review/vaccine-content/independent-source-review.md.", "Distinguishes inactivated injectable vaccine from live oral vaccine and its genuine rare risks." ], "limitationsPublic": [ "Distinguishes inactivated injectable vaccine from live oral vaccine and its genuine rare risks." ] } ], "dossier": "vaccine_umbrella_evidence_2026-10-14.md", "reviewNeeds": "Independent clinical/editorial approval remains pending; no personalized schedule.", "updateTriggers": "New studies, corrected sources, regulatory safety signals and changed local recommendations.", "related": [ { "slug": "mmr", "label": "Measles protection", "reason": "See the MMR evidence and safety information." }, { "slug": "vaccine-ingredients", "label": "Vaccine ingredients", "reason": "Understand amounts, formulations and real reactions." }, { "slug": "vaccine-schedule", "label": "Childhood schedules", "reason": "See what spacing studies can establish." } ], "keyPoints": [ { "text": "Measles vaccination prevents most cases of a highly contagious disease.", "sources": [ 1 ] }, { "text": "HPV and hepatitis B vaccination help prevent cancer.", "sources": [ 2, 3 ] }, { "text": "Large studies do not support claims that vaccines cause autism.", "sources": [ 6 ] } ], "questions": [ { "slug": "vaccine-ingredients", "label": "Vaccine ingredients", "description": "Vaccine ingredients have a strong safety record" }, { "slug": "vaccine-schedule", "label": "Childhood schedules", "description": "Extra vaccine spacing has no proven health benefit" }, { "slug": "covid-cancer-dna", "label": "COVID, cancer & DNA", "description": "COVID vaccines have not been shown to cause cancer" }, { "slug": "hpv-vaccines", "label": "HPV & fertility", "description": "HPV vaccines prevent cancer" }, { "slug": "newborn-hepatitis-b", "label": "Newborn hepatitis B", "description": "Hepatitis B vaccination protects babies from serious liver disease" }, { "slug": "covid-pregnancy", "label": "COVID & pregnancy", "description": "mRNA COVID vaccines can protect during pregnancy" } ], "supplementalDossiers": [], "headline": { "text": "Vaccines are safe and effective", "revision": 1, "status": "owner-approved", "sourceMessageId": null, "approvedAt": "2026-10-14", "authority": "Owner requested exact umbrella headline; implementation approved 2026-10-14 20:52 UTC via parent delegation. Clinical/editorial approval remains separate." }, "language": "en", "jurisdiction": { "kind": "global", "countryCodes": [], "jurisdictionCodes": [], "note": "Evidence and jurisdiction limits are stated beside the relevant claims." }, "claimScope": "", "research": { "dossierRef": "docs/research/vaccine_umbrella_evidence_2026-10-14.md", "reviewedAt": "2026-10-14", "reviewDue": "New studies, corrected sources, regulatory safety signals and changed local recommendations.", "contraryEvidenceConsidered": [], "status": "research draft; editorial/context review separate" }, "status": "researched draft preview", "realWorldClaimReviewed": false, "clinicalEditorialApproved": false }